Moderna Exec Says The Total Respiratory Vaccine Market Could Reach Up To $30B
Portfolio Pulse from Benzinga Newsdesk
During the Investor Day Conference, a Moderna executive stated that the total respiratory vaccine market could reach up to $30 billion. This suggests a significant potential for growth in the vaccine market.
September 13, 2023 | 6:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Moderna's potential growth in the respiratory vaccine market could lead to an increase in its stock price.
The statement from the Moderna executive suggests a significant potential for growth in the respiratory vaccine market. This could lead to increased revenues for Moderna, which would likely have a positive impact on its stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100